Aligos Therapeutics logo

Aligos Therapeutics Share Price Today

(NASDAQ: ALGS)

Aligos Therapeutics share price is $14.4 & ₹1,252.35 as on 6 Mar 2025, 2.30 'hrs' IST

$14.4

0.06

(0.42%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Aligos Therapeutics share price in Dollar and Rupees. Guide to invest in Aligos Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Aligos Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Aligos Therapeutics share price movements

  • Today's Low: $13.78
    Today's High: $14.52

    Day's Volatility :5.07%

  • 52 Weeks Low: $6.76
    52 Weeks High: $46.80

    52 Weeks Volatility :85.56%

Aligos Therapeutics (ALGS) Returns

PeriodAligos Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-48.52%
3.7%
0.0%
6 Months
20.6%
-2.8%
0.0%
1 Year
-41.22%
2.5%
0.0%
3 Years
-76.59%
12.9%
-11.6%

Aligos Therapeutics (ALGS) Key Statistics

in dollars & INR

Previous Close
$14.34
Open
$14.11
Today's High
$14.5164
Today's Low
$13.78
Market Capitalization
$51.5M
Today's Volume
$116.6K
52 Week High
$46.8
52 Week Low
$6.76
Revenue TTM
$6.0M
EBITDA
$-92.7M
Earnings Per Share (EPS)
$-7.18
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-146.69%

How to invest in Aligos Therapeutics Stock (ALGS) from India?

It is very easy for Indian residents to invest directly in Aligos Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aligos Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aligos Therapeutics or ALGS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aligos Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aligos Therapeutics shares which would translate to 0.060 fractional shares of Aligos Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Aligos Therapeutics, in just a few clicks!

Returns in Aligos Therapeutics (ALGS) for Indian investors in Rupees

The Aligos Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Aligos Therapeutics investment value today

Current value as on today

₹63,724

Returns

₹36,276

(-36.28%)

Returns from Aligos Therapeutics Stock

₹41,224 (-41.22%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Aligos Therapeutics (ALGS)

-41%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Aligos Therapeutics Stock from India on INDmoney has decreased by -41% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Aligos Therapeutics

  • Adage Capital Partners Gp LLC

    9.06%

  • EcoR1 Capital, LLC

    7.12%

  • Deep Track Capital, LP

    6.80%

  • Vivo Capital, LLC

    3.95%

  • Vanguard Group Inc

    2.70%

  • Baker Bros Advisors LP

    2.31%

Analyst Recommendation on Aligos Therapeutics

Buy

    75%Buy

    25%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Aligos Therapeutics(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Aligos Therapeutics Stock (ALGS)

What analysts predicted

Upside of 617.59%

Target:

$103.33

Current:

$14.40

Insights on Aligos Therapeutics Stock (Ticker Symbol: ALGS)

  • Price Movement

    In the last 7 days, ALGS stock has moved down by -14.1%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 986.0K → 1.26M (in $), with an average increase of 11.7% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 5.06M → -19.25M (in $), with an average decrease of 480.5% per quarter
  • ALGS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 107.7%
  • ALGS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 126.4%
  • Price to Sales

    ForALGS every $1 of sales, investors are willing to pay $14.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Aligos Therapeutics Technicals Summary

Sell

Neutral

Buy

Aligos Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Aligos Therapeutics (ALGS) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Aligos Therapeutics Inc logo
-44.68%
20.6%
-41.22%
-76.59%
-96.12%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Aligos Therapeutics Inc logo
NA
NA
NA
-10.36
-1.47
-0.67
NA
15.07
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Aligos Therapeutics Inc logo
Buy
$51.5M
-96.12%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Aligos Therapeutics

Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in viral and liver diseases. Its drug candidate, ALG-055009, a small molecule THR-ß agonist that is in the Phase 2a clinical trial for the treatment of non-alcoholic steatohepatitis (NASH). The company also develops ALG-000184, a capsid assembly modulator, which is completed Phase 1b clinical trial to treat chronic hepatitis B (CHB); and ALG-125755, a siRNA drug candidate, which is in Phase I clinical trial for the treatment of CHB. In addition, it develops ALG-097558, which is in Phase 2 clinical trial for the treatment of coronavirus. The company has entered into license and research collaboration agreement with Merck to discover, research, optimize, and develop oligonucleotides directed against a NASH; license agreement with Emory University to provide hepatitis B virus capsid assembly modulator technology; license agreement with Luxna Biotech Co., Ltd. to develop and commercialize products containing oligonucleotides targeting hepatitis B virus genome; and research, licensing, and commercialization agreement with Katholieke Universiteit Leuven to develop coronavirus protease inhibitors. It also has a clinical collaboration with Xiamen Amoytop Biotech Co., Ltd. Aligos Therapeutics, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
Organization
Aligos Therapeutics
Employees
68
CEO
Dr. Lawrence M. Blatt MBA, Ph.D.
Industry
Health Technology

Management People of Aligos Therapeutics

NameTitle
Dr. Lawrence M. Blatt MBA, Ph.D.
CEO, President & Chairman of the Board
Dr. Julian A. Symons DPHIL
Executive VP & Chief Scientific Officer
Ms. Lesley Ann Calhoun CPA
Executive VP, CFO & COO
Ms. Kristina Engeseth M.B.A.
VP and Head of People & Culture
Dr. Sushmita M. Chanda DABT, Ph.D.
Executive Vice President & Chief Development Officer
Dr. David B. Smith Ph.D.
Executive VP & Head of Chemical Operations
Dr. Tse-I Lin Ph.D.
VP of Early Compound Development & Belgian Site Head
Dr. Hardean E. Achneck M.D.
Executive VP & Chief Medical Officer

Important FAQs about investing in ALGS Stock from India :

What is Aligos Therapeutics share price today?

Aligos Therapeutics share price today stands at $14.40, Open: $14.11 ; Previous Close: $14.34 ; High: $14.52 ; Low: $13.78 ; 52 Week High: $46.80 ; 52 Week Low: $6.76.

The stock opens at $14.11, after a previous close of $14.34. The stock reached a daily high of $14.52 and a low of $13.78, with a 52-week high of $46.80 and a 52-week low of $6.76.

Can Indians buy Aligos Therapeutics shares?

Yes, Indians can invest in the Aligos Therapeutics (ALGS) from India.

With INDmoney, you can buy Aligos Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Aligos Therapeutics at zero transaction cost.

How can I buy Aligos Therapeutics shares from India?

It is very easy to buy Aligos Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aligos Therapeutics (ALGS) be purchased?

Yes, you can buy fractional shares of Aligos Therapeutics with INDmoney app.

What are the documents required to start investing in Aligos Therapeutics stocks?

To start investing in Aligos Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Aligos Therapeutics Stock (ALGS)?

Today’s highest price of Aligos Therapeutics (ALGS) is $14.52.

Today’s lowest price of Aligos Therapeutics (ALGS) is $13.78.

What is today's market capitalisation of Aligos Therapeutics?

Today's market capitalisation of Aligos Therapeutics ALGS is 51.5M

What is the 52 Week High and Low Range of Aligos Therapeutics Stock (ALGS)?

  • 52 Week High

    $46.80

  • 52 Week Low

    $6.76

What are the historical returns of Aligos Therapeutics (ALGS)?

  • 1 Month Returns

    -44.68%

  • 3 Months Returns

    20.6%

  • 1 Year Returns

    -41.22%

  • 5 Years Returns

    -96.12%

Who is the Chief Executive Officer (CEO) of Aligos Therapeutics ?

Dr. Lawrence M. Blatt MBA, Ph.D. is the current Chief Executive Officer (CEO) of Aligos Therapeutics.